These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18044770)

  • 1. Frégoli syndrome associated with levodopa treatment.
    Stewart JT
    Mov Disord; 2008 Jan; 23(2):308-9. PubMed ID: 18044770
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 3. Hiccups associated with levodopa in Parkinson's disease.
    Gerschlager W; Bloem BR
    Mov Disord; 2009 Mar; 24(4):621-22. PubMed ID: 19185020
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa toxicity in Parkinson disease.
    Lessell S
    Arch Neurol; 2000 Sep; 57(9):1382. PubMed ID: 10987914
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotoxicity of levodopa: treatment-associated homocysteine increase.
    Müller T; Kuhn W
    Nat Clin Pract Neurol; 2007 Jun; 3(6):E1. PubMed ID: 17549055
    [No Abstract]   [Full Text] [Related]  

  • 6. Othello syndrome in Parkinson disease patients without dementia.
    Cannas A; Solla P; Floris G; Tacconi P; Marrosu F; Marrosu MG
    Neurologist; 2009 Jan; 15(1):34-6. PubMed ID: 19131855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa, motor complications and disease progression.
    Deleu D
    J Neurol Sci; 2008 Oct; 273(1-2):155-6; author reply 156-7. PubMed ID: 18620710
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa-aggravated lateral flexion of the neck and trunk as a delayed phenomenon of unilateral pallidotomy.
    Spanaki C; Zafeiris S; Plaitakis A
    Mov Disord; 2010 Apr; 25(5):655-6. PubMed ID: 20131399
    [No Abstract]   [Full Text] [Related]  

  • 9. Welcome news about levodopa, but uncertainty remains.
    Fahn S
    Ann Neurol; 1998 May; 43(5):551-4. PubMed ID: 9585348
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin rash associated with Sinemet does not equal levodopa allergy.
    Chou KL; Stacy MA
    Neurology; 2007 Mar; 68(13):1078-9. PubMed ID: 17389317
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa--toxic or neuroprotective?
    Weiner WJ
    Nat Clin Pract Neurol; 2006 Oct; 2(10):518-9. PubMed ID: 16990820
    [No Abstract]   [Full Text] [Related]  

  • 12. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
    Miller EM; Nieburg HA
    Dis Nerv Syst; 1974 Jan; 35(1):20-3. PubMed ID: 17894051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early treatment of Parkinson's disease with levodopa].
    Odekerken VJ; Post B; Verschuur CV; de Bie RM
    Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleepiness attacks while driving: adverse effects of new antiparkinson drugs].
    Miranda M; Díaz V; Venegas P; Villagra R
    Rev Med Chil; 2001 May; 129(5):585-6. PubMed ID: 11464545
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
    Pfützner W; Przybilla B
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing long-term therapy for Parkinson disease: options for treatment-associated dyskinesia.
    Stacy M; Galbreath A
    Clin Neuropharmacol; 2008; 31(2):120-5. PubMed ID: 18382184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemiparkinsonism and levodopa-induced dyskinesias following focal nigral lesion.
    Alves R; Barbosa E; Scaff M
    Mov Disord; 2006 Dec; 21(12):2267-8; author reply 2268. PubMed ID: 17078068
    [No Abstract]   [Full Text] [Related]  

  • 18. Impulse control disorders and dopaminergic drugs.
    Morgan JC; Iyer SS; Sethi KD
    Arch Neurol; 2006 Feb; 63(2):298-9; author reply 299. PubMed ID: 16476826
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
    Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
    Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.
    van Laar T; Lammers GJ; Roos RA; Gerritsen JJ; Meinders AE
    Mov Disord; 1998 Jan; 13(1):176-8. PubMed ID: 9452348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.